Literature DB >> 25875590

Development of ESI-MS-based continuous enzymatic assay for real-time monitoring of enzymatic reactions of acetylcholinesterase.

Qiang Fu1, Jun Tang1, Meng Cui2, Zhong Zheng3, Zhiqiang Liu3, Shuying Liu3.   

Abstract

The continuous enzymatic assay based on ESI-MS was developed to real-time monitoring of enzymatic reactions of acetylcholinesterase (AChE). The changes of product concentrations were continuously measured. Calibration curves were established for quantitative calculation. By this method, the Michaelis constant (Km) of acetylcholinesterase was determined to be 70.60±0.93μM and Huperzine A as an effective inhibitor of acetylcholinesterase displayed a mixed inhibition with competitive and noncompetitive inhibition behaviors. The half maximal inhibitory concentration (IC50) and inhibition constant (Ki) value of Huperzine A were also calculated as 48.51±1.16nM and 26.73±0.27nM, respectively. This method provides the rapid and accurate ways to monitor enzyme reactions.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Continuous enzymatic assay; ESI-MS; Half maximal inhibitory concentration (IC50); Inhibition constant (Ki); Michaelis constant (Km)

Mesh:

Substances:

Year:  2015        PMID: 25875590     DOI: 10.1016/j.jchromb.2015.03.022

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.

Authors:  Fang-Xin Wang; Mu-He Chen; Xiao-Ying Hu; Rui-Rong Ye; Cai-Ping Tan; Liang-Nian Ji; Zong-Wan Mao
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.